This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schneider, S S Articles by Brodeur, G M Search for Related Content PubMed PubMed Citation Articles by Schneider, S S Articles by Brodeur, G M

 Previous Article  |  Next Article 

Mol Cell Biol. 1992 December; 12(12): 5563-5570

Isolation and structural analysis of a 1.2-megabase N-myc amplicon from a human neuroblastoma.

Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110.

ABSTRACT

Oncogene amplification is observed frequently in human cancers, but little is known about the mechanism of gene amplification or the structure of amplified DNA in tumor cells. We have studied the N-myc amplified domain from a representative neuroblastoma cell line, SMS-KAN, and compared the map of the amplicon in this cell line with that seen in normal DNA. The SMS-KAN cell line DNA was cloned into yeast artificial chromosomes (YACs), and clones were identified by screening the YAC library with amplified DNA probes that were obtained previously (B. Zehnbauer, D. Small, G. M. Brodeur, R. Seeger, and B. Vogelstein, Mol. Cell. Biol. 8:522-530, 1988). In addition, YAC clones corresponding to the normal N-myc locus on chromosome 2 were obtained by screening two normal human YAC libraries with these probes, and the restriction maps of the two sets of overlapping YACs were compared. Our results suggest that the amplified domain in this cell line is a approximately 1.2-Mb circular molecule with a head-to-tail configuration, and the physical map of the normal N-myc locus generally is conserved in the amplicon. These results provide a physical map of the amplified domain of a neuroblastoma cell line that has de novo amplification of an oncogene. The head-to-tail organization, the general conservation of the normal physical map in the amplicon, and the extrachromosomal location of the amplified DNA are most consistent with the episome formation-plus-segregation mechanism of gene amplification in these tumors.

This article has been cited by other articles:

• Weber, A., Starke, S., Bergmann, E., Christiansen, H. (2006). The Coamplification Pattern of the MYCN Amplicon Is an Invariable Attribute of Most MYCN-Amplified Human Neuroblastomas. Clin. Cancer Res. 12: 7316-7321 [Abstract] [Full Text]  
• Vogt, N., Lefevre, S.-H., Apiou, F., Dutrillaux, A.-M., Cor, A., Leuraud, P., Poupon, M.-F., Dutrillaux, B., Debatisse, M., Malfoy, B. (2004). Molecular structure of double-minute chromosomes bearing amplified copies of the epidermal growth factor receptor gene in gliomas. Proc. Natl. Acad. Sci. USA 101: 11368-11373 [Abstract] [Full Text]  
• Storlazzi, C. T., Fioretos, T., Paulsson, K., Strombeck, B., Lassen, C., Ahlgren, T., Juliusson, G., Mitelman, F., Rocchi, M., Johansson, B. (2004). Identification of a commonly amplified 4.3 Mb region with overexpression of C8FW, but not MYC in MYC-containing double minutes in myeloid malignancies. Hum Mol Genet 13: 1479-1485 [Abstract] [Full Text]  
• Tang, T. C-M., Sham, J. S. T., Xie, D., Fang, Y., Huo, K.-K., Wu, Q.-L., Guan, X.-Y. (2002). Identification of a Candidate Oncogene SEI-1 within a Minimal Amplified Region at 19q13.1 in Ovarian Cancer Cell Lines. Cancer Res. 62: 7157-7161 [Abstract] [Full Text]  
• Lin, L., Prescott, M. S., Zhu, Z., Singh, P., Chun, S. Y., Kuick, R. D., Hanash, S. M., Orringer, M. B., Glover, T. W., Beer, D. G. (2000). Identification and Characterization of a 19q12 Amplicon in Esophageal Adenocarcinomas Reveals Cyclin E as the Best Candidate Gene for this Amplicon. Cancer Res. 60: 7021-7027 [Abstract] [Full Text]  
• Frühwald, M. C, O'Dorisio, M S., Rush, L. J, Reiter, J. L, Smiraglia, D. J, Wenger, G., Costello, J. F, White, P. S, Krahe, R., Brodeur, G. M, Plass, C. (2000). Gene amplification in PNETs/medulloblastomas: mapping of a novel amplified gene within the MYCN amplicon. J. Med. Genet. 37: 501-509 [Abstract] [Full Text]  
• Ueda, T., Sasaki, H., Kuwahara, Y., Nezu, M., Shibuya, T., Sakamoto, H., Ishii, H., Yanagihara, K., Mafune, K.-i., Makuuchi, M., Terada, M. (1999). Deletion of the Carboxyl-Terminal Exons of K-sam/FGFR2 by Short Homology-mediated Recombination, Generating Preferential Expression ofSpecific Messenger RNAs. Cancer Res. 59: 6080-6086 [Abstract] [Full Text]  
• Yoshimoto, M., Caminada de Toledo, S. R., Monteiro Caran, E. M., de Seixas, M. T., de Martino Lee, M. L., de Campos Vieira Abib, S., Vianna, S. M. R., Schettini, S. T., Anderson Duffles Andrade, J. (1999). MYCN Gene Amplification : Identification of Cell Populations Containing Double Minutes andHomogeneously Staining Regions in Neuroblastoma Tumors. Am. J. Pathol. 155: 1439-1443 [Abstract] [Full Text]  
• Godbout, R., Packer, M., Bie, W. (1998). Overexpression of a DEAD Box Protein (DDX1) in Neuroblastoma and Retinoblastoma Cell Lines. J. Biol. Chem. 273: 21161-21168 [Abstract] [Full Text]  
• Torigoe, K, Sato, S, Kusaba, H, Kohno, K, Kuwano, M, Okumura, K, Green, E D, Tsui, L C, Scherer, S W, Schlessinger, D (1995). A YAC-based contig of 1.5 Mb spanning the human multidrug resistance gene region and delineating the amplification unit in three human multidrug-resistant cell lines.. Genome Res 5: 233-244 [Abstract]